Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Antioxidants As a Novel Treatment to Revert Impaired Angiogenic Potential Driven By Metabolic Alterations Observed in Shwachman-Diamond Syndrome Derived Mesenchymal Stromal Cells

Clarissa Gervasoni, Nadia Bertola, Alice Martina Giussani, Erica Dander, Valentino Bezzerri, Andrea Biondi, Paola Corti, Piero Farruggia, Giovanna Giagnuolo, Giuseppe Menna, Anna Pegoraro, Simone Cesaro, Marco Cipolli, Carlo Dufour, Silvia Ravera, Giovanna D'Amico

Blood (2023) 142 (Supplement 1): 4106.

https://doi.org/10.1182/blood-2023-181932

Published: 2023

Journal Articles

Phenotype and Natural History of ELANE and NON ELANE Severe Congenital Neutropenia in Italy: Data from the National Registry

Blood (2022) 140 (Supplement 1): 8331–8333.

https://doi.org/10.1182/blood-2022-166200

Published: 2022

Journal Articles

Study of Angiogenic Potential and Oxidative Metabolism in Mesenchymal Stromal Cells Derived from Shwachman-Diamond Syndrome Patients

Clarissa Gervasoni, Alice Martina Giussani, Nadia Bertola, Erica Dander, Andrea Biondi, Paola Corti, Piero Farruggia, Giuseppe Menna, Marco Cipolli, Valentino Bezzerri, Anna Pegoraro, Simone Cesaro, Carlo Dufour, Enrico Cappelli, Silvia Ravera, Giovanna D'Amico

Blood (2022) 140 (Supplement 1): 5822–5823.

https://doi.org/10.1182/blood-2022-166100

Published: 2022

Journal Articles

Successful of Chemo-Free Treatment with Dasatinib and Blinatumomab in a Pediatric EBF1-PDGFRβ Positive Acute Lymphoblastic Leukemia

Fara Petruzziello, MD, Giovanna Giagnuolo, MD, Giovanni Cazzaniga, PhD, Giuliana Beneduce, MD, Franco Locatelli, Pio Stellato, MD, Grazia Fazio, PhD, Giuseppe Mirabelli, PhD, Giuseppe Menna, MD, Rosanna Parasole, MD

Blood (2018) 132 (Supplement 1): 5213.

https://doi.org/10.1182/blood-2018-99-113829

Published: 2018

Journal Articles

Efficacy of Dasatinib to Treat Molecular Relapse in an Adolescent with Philadelphia-Positive Acute Lymphoblastic Leukemia

Fara Petruzziello, MD, Giovanna Giagnuolo, MD, Giuseppe Menna, MD, Giovanni Cazzaniga, PhD, Giada Muccioli Casadei, PhD, Salvatore Buffardi, MD, Giovanna Maisto, Rosanna Parasole, MD

Blood (2017) 130 (Supplement 1): 5045.

https://doi.org/10.1182/blood.V130.Suppl_1.5045.5045

Published: 2017

Journal Articles

Long-Term Outcome in Children and Adolescents with Chronic Myeloid Leukemia in Chronic Phase Treated with High-Dose Imatinib— the Italian Experience

Blood (2017) 130 (Supplement 1): 1600.

https://doi.org/10.1182/blood.V130.Suppl_1.1600.1600

Published: 2017

Journal Articles

Management of Chronic Myeloid Leukemia in Children and Adolescents According to Local Guidelines.the Italian Experience

Blood (2016) 128 (22): 3083.

https://doi.org/10.1182/blood.V128.22.3083.3083

Published: 2016

Journal Articles

Microrna-150 Regulates STAT5b Levels in Juvenile Myelomonocytic Leukemia (JMML)

Pier Paolo Leoncini, PhD, Alice Bertaina, MDPhD, Dimitrios Papaioannou, MD, Christian Flotho, Riccardo Masetti, MD, Silvia Bresolin, PhD, Giuseppe Menna, MD, Nicola Santoro, Marco Zecca, MD, Giuseppe Basso, Prof, MD, Giovanni Nigita, PhD, Sara Pagotto, PhD, Katia D'Ovidio, PhD, Rossella Rota, Carlo M. Croce, MD, Charlotte Marie Niemeyer, Prof, MD, Franco Locatelli, MD PhD, Ramiro Garzon, MD

Blood (2015) 126 (23): 2851.

https://doi.org/10.1182/blood.V126.23.2851.2851

Published: 2015

Journal Articles

Early Response Does Not Impact on the Long-Term Outcome of Children and Adolescents with Chronic Myeloid Leukemia Treated with High-Dose Imatinib. the Italian Experience

Blood (2015) 126 (23): 2788.

https://doi.org/10.1182/blood.V126.23.2788.2788

Published: 2015

Journal Articles

Response to High Dose Imatinib and Long-Term Outcome in Children and Adolescents with Previously Untreated Chronic Myeloid Leukemia in Chronic Phase. the Italian Experience

Blood (2014) 124 (21): 1812.

https://doi.org/10.1182/blood.V124.21.1812.1812

Published: 2014

Journal Articles

Core Binding Factor Acute Myeloid Leukemia In Pediatric Patients Of The AIEOP AML 2002/01 Trial: Screening and Prognostic Impact Of cKIT Mutations

Elena Manara, PhD, Valeria Bisio, BS, Valzerda Beqiri, MD, Roberto Rondelli, Giuseppe Menna, Concetta Micalizzi, Nicola Santoro, Franco Locatelli, Giuseppe Basso, MD, Martina Pigazzi, PhD

Blood (2013) 122 (21): 2655.

https://doi.org/10.1182/blood.V122.21.2655.2655

Published: 2013

Journal Articles

High Dose Imatinib Is Effective In Children and Adolescents With Chronic Myelogenous Leukemia In Chronic Phase. The Italian Experience

Blood (2013) 122 (21): 1490.

https://doi.org/10.1182/blood.V122.21.1490.1490

Published: 2013

Journal Articles

Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia

Andrea Pession, Riccardo Masetti, Carmelo Rizzari, Maria Caterina Putti, Fiorina Casale, Franca Fagioli, Matteo Luciani, Luca Lo Nigro, Giuseppe Menna, Concetta Micalizzi, Nicola Santoro, Anna Maria Testi, Marco Zecca, Andrea Biondi, Martina Pigazzi, Sergio Rutella, Roberto Rondelli, Giuseppe Basso, Franco Locatelli

Blood (2013) 122 (2): 170–178.

https://doi.org/10.1182/blood-2013-03-491621

Published: 2013

Journal Articles

NOVEL Recurrent Genetic Aberrations in Pediatric AML: An AIEOP AML-2002 Study Group.

Martina Pigazzi, PhD, Elena Manara, PhD, Valeria Bisio, BS, Sabrina Gelain, BS, Sanja Aveic, PhD, Giuseppe Menna, Paolo Pierani, MD, Marco Zecca, Angela Mastronuzzi, MD, Riccardo Masetti, MD, Franco Locatelli, Giuseppe Basso, MD

Blood (2012) 120 (21): 2494.

https://doi.org/10.1182/blood.V120.21.2494.2494

Published: 2012

Journal Articles

Favourable Outcome in Infants with Acute Myeloid Leukemia Treated with the AIEOP AML 2002/01 Protocol

Riccardo Masetti, MD, Martina Pigazzi, PhD, Andrea Pession, Prof, MD, Carmelo Rizzari, MD, PhD, Nicola Santoro, Luca lo Nigro, Matteo Luciani, Giuseppe Menna, Roberto Rondelli, Giuseppe Basso, Franco Locatelli

Blood (2012) 120 (21): 3585.

https://doi.org/10.1182/blood.V120.21.3585.3585

Published: 2012

Journal Articles

Favorable Outcome of Children with Acute Megakaryoblastic Leukemia Treated with the AIEOP AML 2002/01 Protocol

Franco Locatelli, Maria Caterina Putti, Andrea Pession, Prof, MD, Franca Fagioli, MD, Giuseppe Menna, Concetta Micalizzi, Carmelo Rizzari, MD, PhD, Sergio Rutella, MD PhD, Andrea Biondi, MD, Barbara Buldini, Riccardo Masetti, MD, Giuseppe Basso

Blood (2012) 120 (21): 3586.

https://doi.org/10.1182/blood.V120.21.3586.3586

Published: 2012

Journal Articles

Screening of novel genetic aberrations in pediatric acute myeloid leukemia: a report from the AIEOP AML-2002 study group

Martina Pigazzi, Elena Manara, Valeria Bisio, Sanja Aveic, Riccardo Masetti, Giuseppe Menna, Marco Zecca, Andrea Pession, Franco Locatelli, Giuseppe Basso

Blood (2012) 120 (18): 3860–3862.

https://doi.org/10.1182/blood-2012-09-454454

Published: 2012

Journal Articles

GIMEMA-AIEOP AIDA Protocols for the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (APL) In Children: Analysis of 247 Patients Enrolled In Two Sequential Italian Multicenter Trials

Anna Maria Testi, Robin Foa, Gabriella Tomei, Francesco Lo Coco, Andrea Biondi, MD, Andrea Pession, Daniela Diverio, Marco Vignetti, Giuseppe Basso, Franco Locatelli, MD, FRCPath, Carmelo Rizzari, Giuseppe Menna, Maria Luisa Moleti, Nicola Santoro, Giuseppe Fioritoni, Riccardo Masetti, Franco Mandelli

Blood (2010) 116 (21): 871.

https://doi.org/10.1182/blood.V116.21.871.871

Published: 2010

Journal Articles

Results of the AIEOP AML 2002/01 Study for Treatment of Children with Acute Myeloid Leukemia.

Andrea Pession, C. Rizzari, Maria Caterina Putti, Riccardo Masetti, Fiorina Casale, Franca Fagioli, Luca Lo Nigro, Matteo Luciani, Concetta Micalizzi, Giuseppe Menna, Nicola Santoro, Anna Maria Testi, Roberto Rondelli, Andrea Biondi, Giuseppe Basso, Franco Locatelli

Blood (2009) 114 (22): 17.

https://doi.org/10.1182/blood.V114.22.17.17

Published: 2009

Journal Articles

Prevalence and Prognostic Impact of CEBPA mutations in Children with AML Treated with the AIEOP-LAM 2002/01 Protocol.

Giovanni Cazzaniga, Riccardo Masetti, Giulia Ferrari, Tiziana Coliva, Carmelo Rizzari, Roberto Rondelli, Fiorina Casale, Franca Fagioli, Luca Lo Nigro, Matteo Luciani, Concetta Micalizzi, Giuseppe Menna, Maria Caterina Putti, Nicola Santoro, Giuseppe Basso, Franco Locatelli, Andrea Biondi, Andrea Pession

Blood (2009) 114 (22): 2643.

https://doi.org/10.1182/blood.V114.22.2643.2643

Published: 2009

NARROW

Antioxidants As a Novel Treatment to Revert Impaired Angiogenic Potential Driven By Metabolic Alterations Observed in Shwachman-Diamond Syndrome Derived Mesenchymal Stromal Cells

Phenotype and Natural History of ELANE and NON ELANE Severe Congenital Neutropenia in Italy: Data from the National Registry

Study of Angiogenic Potential and Oxidative Metabolism in Mesenchymal Stromal Cells Derived from Shwachman-Diamond Syndrome Patients

Successful of Chemo-Free Treatment with Dasatinib and Blinatumomab in a Pediatric EBF1-PDGFRβ Positive Acute Lymphoblastic Leukemia

Efficacy of Dasatinib to Treat Molecular Relapse in an Adolescent with Philadelphia-Positive Acute Lymphoblastic Leukemia

Long-Term Outcome in Children and Adolescents with Chronic Myeloid Leukemia in Chronic Phase Treated with High-Dose Imatinib— the Italian Experience

Management of Chronic Myeloid Leukemia in Children and Adolescents According to Local Guidelines.the Italian Experience

Microrna-150 Regulates STAT5b Levels in Juvenile Myelomonocytic Leukemia (JMML)

Early Response Does Not Impact on the Long-Term Outcome of Children and Adolescents with Chronic Myeloid Leukemia Treated with High-Dose Imatinib. the Italian Experience

Response to High Dose Imatinib and Long-Term Outcome in Children and Adolescents with Previously Untreated Chronic Myeloid Leukemia in Chronic Phase. the Italian Experience

Core Binding Factor Acute Myeloid Leukemia In Pediatric Patients Of The AIEOP AML 2002/01 Trial: Screening and Prognostic Impact Of cKIT Mutations

High Dose Imatinib Is Effective In Children and Adolescents With Chronic Myelogenous Leukemia In Chronic Phase. The Italian Experience

Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia

NOVEL Recurrent Genetic Aberrations in Pediatric AML: An AIEOP AML-2002 Study Group.

Favourable Outcome in Infants with Acute Myeloid Leukemia Treated with the AIEOP AML 2002/01 Protocol

Favorable Outcome of Children with Acute Megakaryoblastic Leukemia Treated with the AIEOP AML 2002/01 Protocol

Screening of novel genetic aberrations in pediatric acute myeloid leukemia: a report from the AIEOP AML-2002 study group

GIMEMA-AIEOP AIDA Protocols for the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (APL) In Children: Analysis of 247 Patients Enrolled In Two Sequential Italian Multicenter Trials

Results of the AIEOP AML 2002/01 Study for Treatment of Children with Acute Myeloid Leukemia.

Prevalence and Prognostic Impact of CEBPA mutations in Children with AML Treated with the AIEOP-LAM 2002/01 Protocol.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only